Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.6M Buy
768,121
+111,685
+17% +$5.87M ﹤0.01% 2431
2025
Q4
$34.5M Sell
656,436
-26,761
-4% -$1.36M ﹤0.01% 2435
2025
Q3
$37.2M Buy
683,197
+35,573
+5% +$1.91M ﹤0.01% 2275
2025
Q2
$29.8M Buy
647,624
+249,213
+63% +$11.5M ﹤0.01% 2416
2025
Q1
$17.4M Buy
398,411
+116,923
+42% +$5.2M ﹤0.01% 2836
2024
Q4
$11.3M Buy
281,488
+177,353
+170% +$5.89M ﹤0.01% 3300
2024
Q3
$3.17M Buy
104,135
+11,778
+13% +$324K ﹤0.01% 4324
2024
Q2
$2.4M Buy
92,357
+11,529
+14% +$288K ﹤0.01% 4439
2024
Q1
$1.94M Buy
80,828
+77,572
+2,382% +$1.73M ﹤0.01% 4606
2023
Q4
$64.1K Buy
3,256
+1,719
+112% +$31.9K ﹤0.01% 6306
2023
Q3
$30K Buy
1,537
+80
+5% +$1.43K ﹤0.01% 6353
2023
Q2
$29.8K Hold
1,457
﹤0.01% 6413
2023
Q1
$25.8K Sell
1,457
-338
-19% -$5.42K ﹤0.01% 6537
2022
Q4
$22K Buy
1,795
+228
+15% +$2.45K ﹤0.01% 6651
2022
Q3
$13K Sell
1,567
-14,747
-90% -$161K ﹤0.01% 6990
2022
Q2
$187K Buy
16,314
+1,914
+13% +$25.6K ﹤0.01% 5938
2022
Q1
$246K Sell
14,400
-1,995,386
-99% -$54.2M ﹤0.01% 5800
2021
Q4
$85.9M Sell
2,009,786
-267,942
-12% -$13.1M 0.01% 992
2021
Q3
$118M Buy
2,277,728
+252,848
+12% +$12.2M 0.02% 751
2021
Q2
$92.6M Buy
2,024,880
+115,794
+6% +$5.11M 0.01% 890
2021
Q1
$84.5M Sell
1,909,086
-15,646
-0.8% -$686K 0.01% 856
2020
Q4
$72.7M Buy
1,924,732
+592,783
+45% +$21.1M 0.01% 872
2020
Q3
$42M Sell
1,331,949
-541,449
-29% -$20.8M 0.01% 997
2020
Q2
$84.3M Buy
1,873,398
+231,153
+14% +$9.3M 0.02% 609
2020
Q1
$62M Sell
1,642,245
-504,412
-23% -$27.7M 0.02% 655
2019
Q4
$136M Buy
2,146,657
+1,181,318
+122% +$72.6M 0.03% 494
2019
Q3
$57.9M Sell
965,339
-1,168,162
-55% -$80.1M 0.02% 776
2019
Q2
$149M Buy
2,133,501
+870,509
+69% +$52M 0.04% 431
2019
Q1
$66M Buy
1,262,992
+272,069
+27% +$17M 0.02% 704
2018
Q4
$58M Buy
990,923
+115,605
+13% +$7.8M 0.02% 750
2018
Q3
$63.5M Buy
875,318
+107,800
+14% +$7.82M 0.02% 810
2018
Q2
$45.7M Buy
767,518
+64,346
+9% +$4.03M 0.01% 971
2018
Q1
$46.4M Buy
703,172
+82,372
+13% +$6.9M 0.01% 970
2017
Q4
$59.6M Buy
620,800
+171,054
+38% +$16.7M 0.02% 835
2017
Q3
$47M Buy
449,746
+131,877
+41% +$13.5M 0.01% 942
2017
Q2
$31.1M Buy
317,869
+68,310
+27% +$6.73M 0.01% 1190
2017
Q1
$25.5M Buy
249,559
+43,143
+21% +$4.43M 0.01% 1361
2016
Q4
$19.9M Buy
206,416
+14,201
+7% +$1.23M 0.01% 1539
2016
Q3
$16.7M Buy
192,215
+85,193
+80% +$8.56M 0.01% 1597
2016
Q2
$10.4M Buy
107,022
+21,033
+24% +$1.97M ﹤0.01% 1952
2016
Q1
$9.16M Sell
85,989
-7,557
-8% -$667K ﹤0.01% 1929
2015
Q4
$7.67M Sell
93,546
-30,420
-25% -$2.75M ﹤0.01% 2243
2015
Q3
$12.8M Sell
123,966
-684
-0.5% -$85.4K ﹤0.01% 1738
2015
Q2
$15.5M Buy
124,650
+52,995
+74% +$7.51M 0.01% 1716
2015
Q1
$9.39M Buy
71,655
+43,082
+151% +$5.09M ﹤0.01% 2112
2014
Q4
$2.98M Sell
28,573
-38,330
-57% -$5.2M ﹤0.01% 3208
2014
Q3
$12.1M Buy
66,903
+47,154
+239% +$9.91M ﹤0.01% 1865
2014
Q2
$4.15M Buy
19,749
+4,275
+28% +$900K ﹤0.01% 2829
2014
Q1
$3.49M Sell
15,474
-13,599
-47% -$3.49M ﹤0.01% 2924
2013
Q4
$9.4M Buy
29,073
+8,458
+41% +$2.7M ﹤0.01% 2001
2013
Q3
$6.06M Buy
20,615
+7,200
+54% +$1.92M ﹤0.01% 2234
2013
Q2
$3.37M Buy
+13,415
New +$3.66M ﹤0.01% 2704

Other funds holding VEON

Morgan Stanley's VEON Position: Q1 2026 in Review

Morgan Stanley increased its VEON (VEON) stake by 17% in Q1 2026, buying an estimated $5.87M and bringing the position to 768,121 shares worth $35.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2431.

Morgan Stanley first reported a position in VEON in Q2 2013 and has held it in 52 quarters since. The position peaked at $149M in Q2 2019. 101 funds tracked by Wall St. Rank hold VEON as of Q1 2026.

  • Morgan Stanley held 768,121 shares of VEON worth $35.6M as of Q1 2026.
  • Morgan Stanley bought 111,685 VEON shares in Q1 2026, an estimated $5.87M.
  • VEON made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2431 holding.
  • Morgan Stanley first reported a position in VEON in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's VEON position peaked at $149M in Q2 2019.
  • 101 funds tracked by Wall St. Rank held VEON as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.